Key facts
- This page summarizes Norbert G. Riedel's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2026, 17:31.
Norbert G. Riedel - 31 Aug 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)
- Reporting relationship
- Director
- Issuer ticker
- JAZZ
- Reported as of
- 31 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Sep 2026, 17:31:14 UTC
- Prior SEC filing
- 07 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/Paz Dizon, as attorney in fact For: Norbert G Riedel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Norbert G. Riedel filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 02 Sep 2026.
Change
- Previous filing in this sequence was filed on 07 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001161662
Primary reporting owner
RIEDEL NORBERT G
- Relationship
- Director
- Address
- 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
- Signature
- By: /s/Paz Dizon, as attorney in fact For: Norbert G Riedel
- Signature date
- 02 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Tax liability
- Transaction value
- Shares
- -14
- Change %
- -0.16%
- Price
- $244.64*
- Shares after
- 8,615
- Date
- 31 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
JAZZ
transaction
Ordinary Shares
Tax liability
- Transaction value
- Shares
- -1,692
- Change %
- -20%
- Price
- $241.39*
- Shares after
- 6,923
- Date
- 31 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
JAZZ
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,630
- Date
- 31 Aug 2026
- Ownership
- by Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.